Risk factor
Fair trading liquidity
Profitability factor
Undervalued vs peers
About
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., through its various subsidiaries, functions as a pharmaceutical manufacturing holding and investment entity within China. The company's operations encompass the research, development, and production of a broad spectrum of medications. Its therapeutic focus includes pharmaceuticals for oncology, cardiovascular and cerebrovascular conditions, respiratory issues (such as colds and coughs), pediatric care, and antifungal treatments, alongside general health tonics. The firm's product portfolio features both prescription-only drugs and readily available over-the-counter (OTC) remedies. Established in Shanghai, China, in 1992, the company continues to operate from this location.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, underpriced on P/FCF.